Praxis Precision Medicines, Inc.: RBC raises target price to $478 from $462
PRAX•RBC raised its target price for Praxis Precision Medicines to $478 from $462.
Related News
JPMorgan raises Skyworks Solutions target price to $77 from $65
SWKS•
Onto Innovation Inc.: RBC cuts target price to $350 from $400
ONTO•
Philip Morris: JPMorgan reinstates coverage with neutral rating; target price $200
PM•
City Therapeutics, Inc.: Jefferies initiates coverage with buy rating; target price $32
CTY•
No impact on production at Tata India iPhone parts factory as worker deaths occurred while plant shut for festive holidays
AAPL•